Brief report: MECP2 mutations in people without Rett syndrome

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• Mutations in Methyl-CpG-binding protein 2 (MECP2) are the primary cause of Rett syndrome (RTT), a severe neurodevelopmental disorder.
• However, the relationship between MECP2 mutations and RTT clinical presentation is complex, with atypical cases observed.

Observation:

• This report details four individuals with neurodevelopmental abnormalities and pathogenic MECP2 mutations who do not exhibit classic RTT features.
• One case presented with global developmental delay, obsessive-compulsive disorder, and attention deficit hyperactivity disorder, suggesting a broader phenotype.

Findings:

• The study identifies individuals with MECP2 mutations that lead to neurodevelopmental issues but lack the hallmark clinical manifestations of RTT.
• These findings demonstrate that MECP2 mutations can result in a wider range of neurodevelopmental phenotypes than previously recognized.

Implications:

• The results underscore the importance of considering MECP2 mutations in a broader spectrum of neurodevelopmental disorders.
• This research reinforces the consensus that Rett syndrome should be diagnosed based on clinical criteria, acknowledging the variability in MECP2-associated conditions.